Nxera Logo (EUIPO, 07/15/2024)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark Nxera was filed as Figurative mark on 07/15/2024 at the European Union Intellectual Property Office. The current status of the mark is "Application under examination".
Logodesign (Wiener Klassifikation)
#Quadrilaterals with lines #One letter #Letter 'N'
| Trademark form | Figurative mark |
| File reference | 019054464 |
| Application date | July 15, 2024 |
Trademark owner
9-7-2 Akasaka Minato-ku
107-0052 Tokyo
JP
107-0052 Tokyo
JP
Trademark representatives
Prannerstraße 10
80333 München
DE
goods and services
1
Chemical products and proteins for manufacturing chemical and biological pharmaceutical products; chemical products and proteins for the research of chemical and biological pharmaceutical products; chemical products and proteins for diagnostic use, except medical or veterinary uses; proteins and Gprotein- coupled receptors for manufacturing pharmaceutical products; proteins and G-protein -coupled receptors for the research of pharmaceutical products; chemicals and proteins for chemical and biological drug discovery, lead identification and diagnostics; proteins and Gprotein- coupled receptors for drug discovery purposes; chemicals and biologicals, including proteins, transmembrane proteins and G proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, for chemical and biological drug discovery, lead identification and diagnostics; proteins, including transmembrane proteins and G-proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, for use in pharmaceutical research, including, drug discovery purposes; Biological products for use in chemical and biological drug discovery, lead identification and diagnostics; Biological formulation for developing chemical and biological pharmaceutical products; Biological formulation for identifying lead chemical and biological products; Proteins and G-protein-coupled receptors for drug discovery purposes; Gprotein- coupled receptors, transmembrane proteins and parts thereof for use in chemical and biological drug discovery and lead identification
5
Pharmaceutical preparations; medicines; biological products for medical purposes, namely, G-proteincoupled receptors, transmembrane proteins and parts thereof for diagnostics and therapeutic purposes; biological and chemical products for medical use, namely, proteins, G-proteincoupled receptors, modulators of G-protein coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides and parts thereof, for therapeutic purposes; chemicals, proteins and parts thereof for use in medical diagnostics; biological products for therapeutic purposes: biological formulation for diagnostic use; biological formulation for therapeutic use; proteins and G-proteincoupled receptors for drug discovery purposes; biologicals and small chemical entities, including proteins, G-protein-coupled receptors, modulators of G-protein coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides for therapeutic purposes; proteins, Gprotein- coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides for use in medical diagnostics
35
Business management, organisation and administration in the field of chemical products, biological products, pharmaceuticals, design and development of drugs, drug discovery; business management, organisation and administration in the field of research and development services in the pharmaceutical and biopharmaceutical fields, including technologies related to proteins and G-protein-coupled receptors; retail and wholesale services connected with the sale of pharmaceuticals, biological products and chemical and biological preparations
42
Drug and pharmaceutical discovery services; bio-technology, pharmaceutical, chemical and medical testing, research, development, advice, consultancy and information services; research and development services in the pharmaceutical and biopharmaceutical fields, including technologies related to proteins and G-protein-coupled receptors; pharmaceutical research services in chemical and biological drug discovery and development; research and development services for identifying lead chemical compounds; examination and research services in medicinal and synthetic chemistry; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; research, creation, development and provision of chemical and biological drug targets for screening purposes; research, analysis and examination for identification of compounds through automated screening processes; research and development services in chemical and biological pharmaceutical development; medical research laboratory services; provision of information, advisory services and consultancy relating to the aforesaid services
44
Pharmaceutical services; pharmaceutical advice and consultancy for medical purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; all of the aforesaid relating to drug discovery and use of Gprotein- coupled receptors in the design and development of pharmaceutical products
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| August 2, 2024 | Transfer / Change of address, Registered | ||
| July 29, 2024 | Transfer / Change of address, Registered |
ID: 11019054464